Information Access for Birth Control
Recruiting in Palo Alto (17 mi)
Overseen byEleanor Schwarz, MD, MS
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of California, San Francisco
Disqualifiers: Current pregnancy, Menopause, Infertility, others
No Placebo Group
Trial Summary
What is the purpose of this trial?
The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: * Complete a baseline survey * Receive access to web-based educational resources * Complete a brief follow up survey immediately after exploring these web-based resources * Complete a follow-up survey 3 months after enrolling The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Advancing Access Website, Patient-centered Information on Permanent Contraception Website?
Is the Information Access for Birth Control treatment safe for humans?
The research highlights that many women are concerned about the safety of oral contraceptives, but balanced information about risks is important for making informed decisions. Websites and printed materials are useful tools for providing safety information and addressing common concerns like side effects.24567
How is the Advancing Access Website treatment different from other birth control treatments?
The Advancing Access Website is unique because it provides patient-centered information on permanent contraception through an online platform, making it more accessible and informative compared to traditional in-person consultations. This approach is designed to empower patients with knowledge and support their decision-making process regarding permanent birth control options.89101112
Eligibility Criteria
This trial is for women who do not wish to become pregnant in the future. Participants should be considering their options for permanent contraception and willing to complete surveys about their perceptions of contraceptive access after using educational websites.Inclusion Criteria
Self-reported fertility
I speak English or Spanish.
I strongly do not want to become pregnant in the future.
Exclusion Criteria
I have gone through menopause.
Current pregnancy
Infertility
See 3 more
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Baseline Survey and Educational Resource Access
Participants complete a baseline survey and receive access to web-based educational resources
1 week
1 visit (virtual)
Immediate Follow-up
Participants complete a brief follow-up survey immediately after exploring web-based resources
1 week
1 visit (virtual)
3-Month Follow-up
Participants complete a follow-up survey 3 months after enrolling to assess changes in knowledge and perceived access to contraceptives
3 months
1 visit (virtual)
Treatment Details
Interventions
- Advancing Access Website (Behavioral Intervention)
Trial OverviewThe study tests if a new website with patient-centered information on tubal sterilization versus long-acting reversible contraceptives (LARC) affects women's views on contraceptive access, compared to an existing Planned Parenthood website.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Comparative information on tubal sterilization and other long-acting contraceptivesExperimental Treatment1 Intervention
A new website comparing tubal sterilization to vasectomy and long-acting reversible contraceptives
Group II: Information on tubal sterilizationActive Control1 Intervention
Participants will be shown an existing web page developed by Planned Parenthood for people considering tubal sterilization
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of California, San FranciscoSan Francisco, CA
Loading ...
Who Is Running the Clinical Trial?
University of California, San FranciscoLead Sponsor
Agency for Healthcare Research and Quality (AHRQ)Collaborator
Essential Access HealthCollaborator
References
A survey of the effects of oral contraceptive patient information. [2016]A nationwide survey of 1,720 current and 949 former oral contraceptive (OC) users gathered information about receipt, readership, knowledge, opinions, and reported behavioral changes induced by two forms of patient-oriented OC information. A substantial majority of women said they received and read the patient insert dispensed with the drug. However, only about one third of pill users said that they received the longer informational brochure supplied by physicians on patient request. Directions for use and side effects were the most often recalled information. Physician-patient contact patterns were reported as generally unaffected by written patient information. Respondents preferred the longer informational brochure to the insert. Survey results have implications for recently proposed changes in required OC patient information and for the development of patient information on additional prescription drugs.
Oral contraceptive patient information. A questionnaire study of attitudes, knowledge, and preferred information sources. [2019]A questionnaire was designed to assess attitudes, knowledge, and views and sources of drug information on oral contraceptives, with particular attention to the role of the patient-oriented package insert. An analysis of 828 completed questionnaires shows that many women are apprehensive about the safety of oral contraceptives. The impact of the patient-oriented oral contraceptive insert on the women surveyed appears to be positive. The present labeling is read and found useful by most oral-contraceptive users. Patients were variably informed about the correct use and side effects discussed in current labeling, suggesting a need for improved transmission of important drug information. Patients preferred information from health professionals and printed sources over media sources. Balanced label information about risks of oral contraceptives should be made available to improve the likelihood of sound risk-benefit judgments.
Developing a Youth Contraception Navigator Program: A Human-Centered Design Approach. [2023]To determine key elements of a contraception navigator program that provides a personalized approach to overcoming patient-specific barriers by a trained navigator in central Indiana.
Patient and provider perspectives on Bedsider.org, an online contraceptive information tool, in a low income, racially diverse clinic population. [2015]To explore patient and provider perspectives regarding a new Web-based contraceptive support tool.
Using the EngagedMD multimedia platform to improve informed consent for ovulation induction, intrauterine insemination, and in vitro fertilization. [2019]To study patient and provider feedback on how a multimedia platform (EngagedMD) helps patients to understand the risks and consequences of in vitro fertilization (IVF), ovulation induction (OI), and intrauterine insemination (IUI) treatments and the impact of the informed consent process.
Surfing on the morning after: analysis of an emergency contraception website. [2019]The introduction of widespread nonprescription delivery of hormonal emergency contraception (EC) calls for development of innovative tools to provide information to and gather feedback from EC users. Individuals seeking confidential information on sexual health and contraception are increasingly turning to the Internet as the resource of choice. This study employed analytical software and manual content analysis to examine the use of a website dedicated to an EC product (www.norlevo.com) over the course of 2 years. Frequency of visits to and pageviews of the site increased consistently over the 2-year time period, and the bulk of the visitors to the site were EC users seeking responses to frequently asked questions. The most common concern raised by users was the occurrence of spotting and menstrual bleeding following EC use. This analysis reveals that within the context of nonprescription access to hormonal EC, a website can constitute a potent educational tool for health professionals and EC users and provide a valuable source of post-marketing feedback on product use.
Patient attitudes about two forms of printed oral contraceptive information. [2019]The desired form and style of written drug information for patients were assessed in a national survey of oral contraceptive (OC) users. These women were queried about two forms of OC information: a short insert included with dispensed drugs and a longer brochure delivered by the physician upon patient request. Longer and more detailed information, especially concerning drug dangers and directions for use, was strongly preferred. Younger and more educated women were more likely to report receiving the OC brochure and to desire more comprehensive information. Most respondents found information in both the insert and the brochure clear and useful, and felt it was important to include written information with other prescription drugs. The longer brochure was preferred over the shorter insert as a model of drug information to be included with additional drugs.
Feasibility and acceptability of using a web-based contraceptive support tool in a university health clinic. [2021]Objective: To evaluate feasibility of integrating Bedsider.org, a web-based contraceptive decision support tool, at a university health clinic (UHC). Participants: Female students (ages 18-29) seeking contraceptive care at the UHC were enrolled in September 2015 (n = 46). Methods: Providers recruited eligible patients during reproductive healthcare visits and introduced Bedsider. Surveys were administered immediately following the visit and a follow-up 2-4 weeks later. Electronic health records through 6 weeks post-enrollment were extracted. Results: Most patients had positive views toward Bedsider and appreciated receiving information during their UHC encounters. None were using long-acting reversible contraceptives (LARC) at enrollment. At follow-up, two patients self-reported IUD use. Among those recently sexually active, use of more effective contraceptive methods increased from 65% to 74%; 11% had initiated or were scheduled to receive a LARC. Conclusion: Bedsider can be feasibly integrated into UHC visits and may support women's selection of more effective contraceptive methods, including LARCs.
Patient-provider communication before and after implementation of the contraceptive decision support tool My Birth Control. [2020]To compare differences in patient-provider communication among patients who, prior to contraceptive counseling, used or did not use a decision support tool ("My Birth Control") which has educational and interactive modules and produces a provider printout with the patient's preferences.
Googling long-acting reversible contraception: A scoping review examining the information available online about intrauterine devices and contraceptive implants. [2023]The internet is an important source of health information, however, the quality of information about long-acting reversible contraception (LARC, including intrauterine devices (IUDs) and contraceptive implants) found online is largely unknown.
Contraceptive Access at Federally Qualified Health Centers During the South Carolina Choose Well Initiative: A Qualitative Analysis of Staff Perceptions and Experiences. [2022]Introduction: Federally qualified health centers (FQHCs) provide essential contraceptive services to low-income individuals; yet, access to all method options, notably intrauterine devices (IUDs) and implants, may be limited at non-Title X FQHCs. The South Carolina (SC) Choose Well initiative is a statewide contraceptive access initiative that was launched in 2017 and extends into 2022. Choose Well established a collaborative network between training and clinical partners and is aimed at facilitating implementation of contraceptive care best practices through capacity-building and training of clinical and administrative staff in partner organizations. The initiative provided funding for workforce expansion and contraceptive methods. We examined perceptions of staff from Choose Well-participating FQHCs regarding contraceptive access during the first 2 years of the initiative, including factors that facilitated or posed access challenges as well as sustaining factors. This study informs the process evaluation of Choose Well while providing data critical for uncovering and scaling up contraceptive access initiatives. Materials and Methods: Interviews were conducted with FQHC staff (n = 34) in 2018 and 2019 to assess Choose Well implementation and were recorded, transcribed, and double-coded via at least 80% interrater reliability or consensus coding. Data were analyzed according to clinical and administrative factors influencing contraceptive access. Results: Increased capacity for contraceptive counseling and provision through training and external funding for IUDs and implants were the most noted clinical factors facilitating access. Streamlining workflow processes was also a facilitator. Buy-in and engagement among staff and leadership emerged as a facilitator at some clinics and as a barrier at others. Policy/structural factors related to costs of devices and insurance coverage were identified as threats to sustainability. Conclusions: The Choose Well initiative contributed to the perception of an increase in contraceptive access at participating FQHCs in SC. Statewide contraceptive access initiatives have the potential to support FQHCs in meeting their clients' contraceptive needs. Organizational buy-in, sustainability of funding, and training are key to realizing the full potential of these initiatives.
Public perception of pharmacist-prescribed self-administered non-emergency hormonal contraception: An analysis of online social discourse. [2022]Increasing access to hormonal contraception reduces unintended pregnancies. One strategy gaining momentum is allowing patients to access hormonal contraception directly from pharmacists. Commentary on online news articles provides a naturalistic and real-time data source to assess public perceptions on timely and often controversial issues.